HMOX1 and glioblastoma: As such, it is not surprising that HO-1 is widely expressed in cancer (i.e. glioblastoma, melanoma, bladder, breast, colorectal, renal cancer, prostate) (21) and that its overexpression correlates with cancer invasiveness, resistance to therapies and poor prognosis in different tumors (21–26).